EceMutluMD

Gastroenterology • Chicago, IL

Gastrointestinal Cancer, Inflammatory Bowel Disease, Nutrition

Associate Professor, Internal Medicine, Rush Medical College of Rush Univ

Join to view full profile

Dr. Mutlu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mutlu's full profile

Already have an account?

Office
1725 W Harrison St
Suite 207
Chicago, IL 60612
Phone+1 312-942-5861

Education & Training

Rush University Medical CenterFellowship, Gastroenterology, 1999 - 2001
Loyola University Medical CenterFellowship, Gastroenterology, 1998 - 1999
Loyola University Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1994 - 1995
Istanbul University FomClass of 1992

Certifications & Licensure

IL State Medical License 1997 - 2026
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACG) American College of Gastroenterology

Clinical Trials

Dietary Treatment of Crohn's Disease Start of enrollment: 2006 Sep 01
Completed
Phase 1, Phase 2
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease Start of enrollment: 2013 Mar 01
Completed
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Completed
Phase 3
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II) Start of enrollment: 2014 Mar 01
Terminated
Phase 2
Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk Start of enrollment: 2018 Aug 01
Active, not recruiting
Not Applicable
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) Start of enrollment: 2017 Sep 15
Completed
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Neighborhood homicide rate and odds of colorectal adenoma among adult patients seeking colonoscopy.
Alyshia Hamm, Evgenia Karayeva, Manoela Lima Oliveira, Nabil Kahouadji, Paul Grippo
JNCI Cancer Spectrum. 2024-11-01
4 citations
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study.
Tina Aswani-Omprakash, Madhura Balasubramaniam, Josie McGarva, Anjali Pandit, Ece A Mutlu
Indian Journal of Gastroenterology. 2024-02-01
2 citations
Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meeting.
Jun Sun, M Nedim Ince, Clara Abraham, Terrence Barrett, Lisa A Brenner
Gut Microbes. 2023-12-01

Press Mentions

New, 'Designer' Fiber May Help Address Fiber Intolerance, Ease IBS SymptomsJanuary 16th, 2014

Professional Memberships

American College of Gastroenterology - ACG
Fellow